Detalles de la búsqueda
1.
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
N Engl J Med;
383(21): 2041-2052, 2020 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32706953
2.
A randomized trial comparing dual axis rotational versus conventional coronary angiography in a population with a high prevalence of coronary artery disease.
J Interv Cardiol;
27(5): 456-64, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25132588
3.
Effect of Nuts on Anthropometric and Glycemic Indexes and Blood Pressure in Secondary Cardiovascular Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Nutr Rev;
2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38781314
4.
Antivirals for adult patients hospitalised with SARS-CoV-2 infection: a randomised, phase II/III, multicentre, placebo-controlled, adaptive study, with multiple arms and stages. COALITION COVID-19 BRAZIL IX - REVOLUTIOn trial.
Lancet Reg Health Am;
20: 100466, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36908503
5.
Risk for Obstructive Sleep Apnea by Berlin Questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study.
Am J Hypertens;
21(7): 832-5, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18451807
6.
Late Diagnosed Left Coronary to the Pulmonary Artery Large Fistulae: An Interesting and Incidental Cath Lab Finding.
Case Rep Cardiol;
2016: 1459607, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28053791
7.
Seguimento de 12 meses de pacientes complexos tratados com stentsfarmacológicos liberadores de everolimus XIENCE V® na prática diária resultados do registro brasileiro BRAVO / Twelve-month follow-up of complex patients treated with the Xience V everolimus drug-eluting stents in daily practice results of the BRAVO Brazilian Registry
Rev. bras. cardiol. invasiva;
23(1): 22-27, abr.-jun.2015. tab
Artículo
en Portugués
| LILACS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: lil-782171
8.
Seguimento angiográfico e clínico tardio do novo stent farmacológico não-polimérico liberador de paclitaxel para o tratamento de lesões coronárias De Novo: resultados do Estudo PAX-B / Late clinical and angiographic follow-up of the new non-polymeric paclitaxel-eluting stent for the treatment of De Novo coronary lesions: outcomes of the PAX-B Study
Rev. bras. cardiol. invasiva;
20(2): 146-154, abr.-jun. 2012. tab
Artículo
en Portugués
| LILACS, SES-SP | ID: lil-649565
9.
Stents farmacológicos libertadores de everolimus Xience TM V no tratamento de pacientes com lesões coronárias complexas na prática diária: resultados iniciais do Registro Brasileiro BRAVO / Xience TM V everolimus-eluting stents in the treatment of patients with complex coronary lesions in the daily clinical practice: early results of the Brazilian Registry BRAVO
Rev. bras. cardiol. invasiva;
19(4): 357-366, dez. 2011. tab, graf
Artículo
en Portugués
| LILACS, SES-SP | ID: lil-618780
Resultados
1 -
9
de 9
1
Próxima >
>>